Impact of Amyloid Imaging on Drug Development in Alzheimer’s Disease

по Mathis, C.A., Lopresti, B.J., Klunk, W.E.
Опубликовано 2007

Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease

по Ikonomovic, M.D., Klunk, W.E., Abrahamson, E.E., Wuu, J., Mathis, C.A., Scheff, S.W., Mufson, E.J., DeKosky, S.T.
Опубликовано 2011

Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline

по Tudorascu, DL, Laymon, CM, Zammit, M, Minhas, DS, Anderson, SJ, Ellison, PA, Zaman, S, Ances, BM, Sabbagh, M, Johnson, SC, Mathis, CA, Klunk, WE, Handen, BL, Christian, BT, Cohen, AD
Опубликовано в: Alzheimers Dement (N Y) (2020)

Reduced binding of Pittsburgh Compound-B in areas of white matter hyperintensities

по Goodheart, A.E., Tamburo, E., Minhas, D., Aizenstein, H.J., McDade, E., Snitz, B.E., Price, J.C., Mathis, C.A., Lopez, O.L., Klunk, W.E., Cohen, A.D.
Опубликовано в: Neuroimage Clin (2015)

Anti-Amyloid Effects of Small Molecule Aβ-Binding Agents in PS1/APP Mice

по Cohen, A.D., Ikonomovic, M.D., Abrahamson, E.E., Paljug, W.R., DeKosky, S.T., Lefterov, I.M., Koldamova, R.P., Shao, L., Debnath, M.L., Mason, N.S., Mathis, C.A., Klunk, W.E.
Опубликовано 2009

The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by [(11)C]PiB

по Lao, PJ, Betthauser, TJ, Hillmer, AT, Price, JC, Klunk, WE, Mihaila, I, Higgins, AT, Bulova, PD, Hartley, SL, Hardison, R, Tumuluru, RV, Murali, D, Mathis, CA, Cohen, AD, Barnhart, TE, Devenny, DA, Mailick, MR, Johnson, SC, Handen, BL, Christian, BT
Опубликовано в: Alzheimers Dement (2015)